Pharmaceutical Compounding Safety: South Africa’s Warning
Pharmaceutical compounding safety is the focus as South Africa reviews rules for GLP-1 weight-loss injections. What regulators found and what is proposed.
Pharmaceutical compounding safety is the focus as South Africa reviews rules for GLP-1 weight-loss injections. What regulators found and what is proposed.
Vanda Pharmaceuticals social anxiety drug VQW-765 is on hold after a Phase 3 miss. What it means for the pipeline and the alpha-7 approach.
BD ChloraPrep applicator recall: how one contaminated component forced whole-kit destruction in an AVID Medical IV start kit lot. Supply-chain lessons.
CDC measles outbreak response: what Epi-Aid brings to Pennsylvania as cases hit 1,222, and why counting the true burden of an outbreak is hard.
Mosquito-borne diseases Europe: record West Nile season, 1,715 EU cases, first Belgian infections. How surveillance and mosquito control work.
Labcorp OPKO Health deal: $722M cash plus up to $150M for select BioReference assets. The economics, the logic and what could still change.
Revolution Medicines Rasonque gets a CHMP positive opinion for pretreated metastatic pancreatic cancer. FDA approved it in August. What comes next in the EU.
AstraZeneca biotechnology partnership: $40M upfront, up to ~$1.46B in milestones with insitro for MASH and heart disease. See what is guaranteed.
Indian pharma companies overseas: Zydus plans a $20M-plus Sri Lanka plant with a local partner, operations from 2028. What it shows and what it does not.